Market Overview:
Human papillomavirus (HPV) is a viral infection that’s passed between people through skin-to-skin contact. HPV is a major cause of vulva, cervical, vagina, anus, penis, throat, and mouth cancer. Cytomegalovirus (CMV) is the most common herpesvirus infection. These infections can spread through sexual and non-sexual contact with body secretions (fluids). CMV is also known as Human Herpes Virus 5 and is most commonly transmitted to a developing fetus.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 @
https://www.coherentmarketinsights.com/insight/request-sample/2707
Market Drivers:
Increasing prevalence of HPV and CMV is expected to augment growth of the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market during the forecast period. For instance, in January 2018, as per the Centers for Disease Control and Prevention (CDC), more than 50% of American adults suffer from CMV infection.
Moreover, frequent approvals of novel therapies are expected to boost the growth of the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market. For instance, in January 2016, Fate Therapeutics, Inc. announced that FDA has cleared its investigational new drug (IND) application for ProTmune, a programmed cellular immunotherapy. It is used to prevent acute Graft- versus-Host Disease (GvHD) infection and CMV infection. In January 2018, Shire announced that FDA had granted Breakthrough Therapy Designation to Maribavir, its Phase III investigational drug to treat CMV infections.
Furthermore, increasing focus on developing novel therapeutics is expected to propel growth of the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market. For instance, in May 2014, Atara Biotherapeutics began a clinical study of preemptive adaptive CMV-specific T cells (CMVpp65) infusion to prevent refractory CMV infection. These cells can clear CMV infection and restore antiviral immunity. While, in July 2012, the University of Alabama at Birmingham initiated clinical phase II study of quadrivalent HPV recombinant vaccine to treat HPV (types 6, 11, 16, 18) infections.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/2707
Key Players:
Key players involved in the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market are Fresenius Kabi, Biotest AG, Roche Holding AG, Perrigo Company plc, Clinigen Group, Fougera Pharmaceuticals, Merck Sharp & Dohme, GlaxoSmithKline, Bausch Health, Allergan, and Lee’s Pharmaceutical Holdings, among others.
Detailed Segmentation:
Global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Drug Type:
-
- HPV Therapeutics
- Immunomodulatory Agents
- Interleukins
- Cytokines
- Chemokine
- Others
- Keratolytic Agents
- TCA (Trichloroacetic Acid)
- Bichloracetic Acid
- Anti-neoplastic Agents
- Sinecatechins
- Immunomodulatory Agents
- CMV Therapeutics
- Ganciclovir/Valganciclovir
- Foscarnet
- Cidifovir
- Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Application:
- HPV Therapeutics Application
- Genital warts
- Cervical cancer
- Epidermodysplasia Verrucifdormis
- Others
- CMV Therapeutics Application
- CMV Retinitis
- Pneumonia
- Gastrointestinal ulcers
- Encephalitis
- Others
- Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- HPV Therapeutics Application
- HPV Therapeutics
Reasons to Buy this Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics market
➡Leading company profiles reveal details of key Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report @
https://www.coherentmarketinsights.com/insight/buy-now/2707
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Industry Impact
Chapter 2 Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics (Volume and Value) by Type
2.3 Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Sales, Consumption, Export, Import by Regions
Chapter 5 North America Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Analysis
Chapter 6 East Asia Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Analysis
Chapter 7 Europe Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Analysis
Chapter 8 South Asia Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Analysis
Chapter 9 Southeast Asia Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Analysis
Chapter 10 Middle East Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Analysis
Chapter 11 Africa Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Analysis
Chapter 12 Oceania Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Analysis
Chapter 13 South America Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Analysis
Chapter 14 Company Profiles and Key Figures in Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Business
Chapter 15 Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Forecast (2021-2028)
Chapter 16 Conclusions
Research Methodology….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837